US FDA grants priority review to Roche’s Actemra/RoActemra to treat COVID-19 in hospitalised adults EP News Bureau Apr 4, 2022 If approved, Actemra/RoActemra would be the first US FDA-approved immunomodulator for the treatment of COVID-19 in hospitalised…
WHO grants prequalification of Roche’s Actemra/RoActemra for patients with severe COVID EP News Bureau Feb 14, 2022 Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra,…
CHMP recommends EU approval of Actemra/RoActemra to treat patients with severe COVID-19 EP News Bureau Dec 7, 2021 Actemra/RoActemra reduced the risk of death in patients with severe COVID-19, as evidenced by a review of four phase-III studies.…
